Pharmaceutical Biology | 2021

Cytotoxic furanosesquiterpenoids and steroids from Ircinia mutans sponges

 
 
 
 
 
 
 
 
 

Abstract


Abstract Context Ircinia mutans Wilson (Irciniidae) is a sponge with antimicrobial and cytotoxic constituents. Objective Our objective was to characterise the cytotoxic constituents of two seasonal collections of I. mutans. Materials and methods The sponges were extracted in methanol-dichloromethane and their constituents were purified and characterised using column chromatography, GC-MS, 1\u2009D and 2\u2009D NMR. Anti-proliferative activities of the compounds, were evaluated using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) colorimetric assay (0.25–100\u2009μg/mL, 72\u2009h) against leukaemia (MOLT-4), breast (MCF-7) and colon cancer (HT-29) human cells. Results Three furanosesquiterpoids; furodysin (1), ent-furodysinin (2) and furoircin (3) and ten sterols were characterised in I. mutans, for the first time. Cholesterol (4), cholesta-5, 7-dien-3β-ol (5) and ergosterol (6) were determined in the sponge from the winter collections, while cholesta-5, 22-dien-3β-ol (7), 24-methyldesmosterol (8), campesterol (9), stigmasterol (10), γ-ergostenol (11), chondrillasterol (12) and γ-sitosterol (13) were detected in the summer samples. The steroids from the winter collection exhibited cytotoxic activity with IC50 values of 13.0\u2009±\u20090.9, 11.1\u2009±\u20091.7 and 1.1\u2009±\u20090.4\u2009µg/mL, against the mentioned cancer cell lines, respectively, while those from the summer sample, showed greater activity, IC50 = 1.1\u2009±\u20090.2\u2009μg/mL against MOLT-4. The purified steroids showed potent MOLT-4 cytotoxic activity, IC50 values = 2.3–7.8\u2009µg/mL. Discussion and conclusion The present study suggests that I. mutans is a rich source of cytotoxic steroids, and introduces 3 as new natural product. Considering the high cytotoxic activity of the steroids, these structures could be candidates for anticancer drug development in future research.

Volume 59
Pages 575 - 583
DOI 10.1080/13880209.2021.1920620
Language English
Journal Pharmaceutical Biology

Full Text